Brief: Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics
17/09/2026 05:51
BRIEF-Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics SK Biopharmaceuticals Co Ltd 326030.KS:
SIGNS LICENSING-IN CONTRACT WITH 1ST BIOTHERAPEUTICS
DEAL SIZE UP TO 430.8 BILLION WON
UPFRONT PAYMENT 2.5 BILLION WON
Source text: [ID:]
Further company coverage: 326030.KS
Recent news on SK Biopharmaceuticals
See all newsBrief: Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics
US FDA pauses new enrollment in Biohaven's epilepsy drug trials (updated)
US FDA pauses new enrollment in Biohaven's epilepsy drug trials
Biohaven jumps on SK Biopharma epilepsy licensing deal worth up to $795 million
U.S. STOCKS ON THE MOVE-Meta, Kohl's, J.M. Smucker